Introduction to Monoclonal Antibodies for Cancer Therapy

a new report on "Monoclonal Antibodies in Cancer Therapy: World Market Prospects 2010-2025" explains how this market will develop, and where the opportunities will lie.

Online PR News – 04-August-2010 – – Monoclonal Antibodies in Cancer Therapy: World Market Prospects 2010-2025

In 2009, monoclonal antibodies for cancer therapy generated total revenues of over $18bn worldwide. From 2010, that sector will benefit from new drugs and expanding indications for existing products. ( http://www.bharatbook.com/detail.asp?id=101007&rt=Monoclonal-Antibodies-in-Cancer-Therapy-World-Market-Prospects-2010-2025.html )

Cancer incidence and prevalence are rising worldwide; studies reveal that incidence will rise by up to 40% by 2025. Worldwide, the treatment of cancer is a priority for healthcare providers, with high demand for efficacious and well-tolerated therapies. Where is the monoclonal antibody therapy market for cancer heading - technologically and commercially - from 2010 onwards? Our new report covers such questions, providing the information that you need.

Our new report - Monoclonal Antibodies in Cancer Therapy: World Market Prospects 2010-2025 - explains how this market will develop, and where the opportunities will lie. We show how you can benefit from its developments and potential. There remain many unmet therapeutic needs in the treatment of cancer. There is also increasing demand for cancer monoclonal antibodies in developing countries. Novel monoclonal antibodies that demonstrate improved safety profiles combined with high efficacies can gain significant market shares from 2010 onwards. There remain high revenues to be made in this sector from 2010 to 2025, our new report explains.

Monoclonal Antibodies in Cancer Therapy: World Market Prospects 2010-2025 covers the following monoclonal antibodies in detail:

* Avastin
* Mabthera/Rituxan
* Herceptin
* Erbitux
* Vectibix
* Campath.

What sort of monoclonal antibodies are likely to enter the market from 2010 onwards? Where will the main opportunities lie, and what are the drivers and restraints in this market area? This report will provide you with the information that you need to understand current trends and future directions in the industry and market.

For more information kindly visit : http://www.bharatbook.com/detail.asp?id=101007&rt=Monoclonal-Antibodies-in-Cancer-Therapy-World-Market-Prospects-2010-2025.html

Related Reports

Monoclonal antibodies: 2009 update
http://www.bharatbook.com/detail.asp?id=124900&rt=Monoclonal-antibodies-2009-update.html

The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
http://www.bharatbook.com/detail.asp?id=126919&rt=The-Future-of-Monoclonal-Antibodies-Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html

Or

Contact us at :

Global Knowledge Research Centre
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@globalknowledgeresearch.com
Website: www.globalknowledgeresearch.com

Bookmarkse-mailGoogledel.icio.usStumbleUponSlashdotFurlDiggTechnoratiYahooMyWebBlinkListSpurlRawSugarWists
 
 
Contact Information